Sinus Augmentation With Dental Implant

TerminatedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Maxillary Sinus Bone Loss
Interventions
DEVICE

INFUSE® Bone Graft

Patients will be treated with the commercially available INFUSE® Bone Graft material applied to an ACS in the area of the dental implant on Day 0 (Surgery). A follow-up visit will take place 2 weeks after implant of the INFUSE® Bone Graft material, or as regularly scheduled as the standard of care (SOC) for the facility. Patients will return to the facility for final End of Study (EOS) assessments 6 months after surgery for placement of the appropriate prosthetic, and assessment of osseointegration and stability. Between the follow-up visit and the EOS visit, patients will be seen as per the SOC schedule for the facility.

Trial Locations (5)

19104

Philadelphia

28037

Denver

75246

Dallas

77063

Houston

92835

Fullerton

Sponsors
All Listed Sponsors
collaborator

Averion International Corporation

INDUSTRY

lead

Medtronic Spinal and Biologics

INDUSTRY

NCT00991393 - Sinus Augmentation With Dental Implant | Biotech Hunter | Biotech Hunter